Navigation Links
Vapotherm(R) Precision Flow(TM) Receives FDA 510(k) Clearance
Date:8/7/2008

STEVENSVILLE, Md., Aug. 7 /PRNewswire-USNewswire/ -- Vapotherm, the global leader in High Flow Oxygen Therapy products, has received 510(k) clearance from the Food and Drug Administration (FDA) for Precision Flow(TM), the first high flow humidification system to integrate gas blending, flow control and humidification technology into one device for the optimal conditioning of nasal cannula inspired gases.

Other Vapotherm products are currently used in neonatal, pediatric and adult applications in hundreds of hospital locations throughout the US and in over twenty countries. "The Vapotherm brand has become synonymous with the category of high flow oxygen therapy. Precision Flow(TM) illustrates our continued commitment to raising the technology standard and delivering to the respiratory community the state of the art in noninvasive respiratory assistance," said Robert Storey, President and CEO of Vapotherm.

Precision Flow(TM) was developed with extensive input from clinical professionals in neonatology, pediatrics and adult respiratory care. The result is a device that combines performance, safety and ease of use for optimal patient outcomes. "Vapotherm has been utilized with great success in our neonatal unit. The new device offers our staff the same high flow therapy benefits, with improved ease of use and performance features," said Dr. Eleri Adams of the John Radcliffe Hospital at Oxford, England, a major teaching hospital of NHS who has recently begun using Precision Flow(TM).

With the FDA clearance, the Company has initiated full-scale production. Precision Flow(TM) is exclusively distributed in the US by a network of specialty medical sales and marketing organizations. "The Vapotherm product line has been a top performer for us," said Don Reiter, President of Special Respiratory Care, Inc., a leading distributor of respiratory products. "Based on feedback and early orders from our customers, we expect Precision Flow(TM) to dominate th
'/>"/>

SOURCE Vapotherm, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years
2. Varian Medical Systems to Unveil RapidArc(TM) Volumetric Arc Therapy and Other Products Designed to Speed Delivery of Precision Radiotherapy and Brachytherapy
3. New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput
4. Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order
5. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%
6. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
7. Precision Therapeutics Adds 8 Million Covered Lives Under Contract
8. Applied Precision Announces Sale of Life Sciences Business Unit to Senior Management and Telegraph Hill Partners
9. Precision Therapeutics President and CEO Sean McDonald Named Ernst & Young Entrepreneur of the Year(R) 2008 Regional Award Winner
10. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
11. DaVita Receives Civil Complaint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Makers of Powerful Painkillers Present Safety Plans 2
...n Ignagni, President and CEO of America,s Health I...ay on the cost containment framework presented to ... join with leading stakeholders to help advance a ...ness of our country. We strongly believe that all ...
...announced today that it is partnering with the Cit...ad of H1N1 and other viruses. In support of protec...ing gel at more than 400 new sanitizing stations t...o Department of Public Health for their leadership...
...ersity of Queensland in Australia have found a tra...he South Pacific, to be safe and effective in redu...in the Springer journal Psychopharmacology , the ...a was prescribed in the form of tablets. , Lead ...
... Derma Sciences, Inc. (OTC Bulletin Board: DSC...nounced plans to release its first quarter 2009 re...Company will hold a conference call that same day ... to access the call. You may also access this call...
...s(TM) secures 24/7 physician access to serve offsh...N, May 11 InPlace Medical Solutions, the first fu...lemedicine, has achieved another first in the offs...cy medicine and internal medicine physicians who a...
...1 Bill Carlson, vice president, marketing for GHX... Executive magazine,s 2009 Pros to Know for his c...chain in healthcare. With more than 20 years exper...est and fastest-growing expense category for most ...
Other Medicine News:Health News:AHIP Statement on Cost Containment Framework 2Health News:Harris Joins City of Chicago in Support of Maintaining Good Health Habits 2Health News:Research finds kava safe and effective 2Health News:Derma Sciences Announces Date of Its First Quarter 2009 Earnings Release and Conference Call 2Health News:The Doctor Is In, Around the Clock 2Health News:The Doctor Is In, Around the Clock 3Health News:GHX Vice President Bill Carlson Named to Supply & Demand Chain Executive's 2009 Pros to Know List 2
(Date:12/4/2009)Workers Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, Dec. 4 Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public abo
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Researchers design new graphene based nano material with magnetic properties 13810 1Researchers design new graphene based nano material with magnetic properties 13810 2BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 1BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 2BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 3BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 4Pew poll 3A 9 in 10 Iowa voters support more government oversight of food 56091 1Pew poll 3A 9 in 10 Iowa voters support more government oversight of food 56091 2
...ct. 30 Schering-Plough Corp.,and the European Org...,(EORTC) announced long-term follow-up results fro...RTC and the National Cancer Institute of Canada,(N...emotherapy,(temozolomide) Capsules and radiation t...s with glioblastoma multiforme (GBM) versus radiat...
...d Screening Agreement Fuels Discovery of Novel Com...atives with PF-3512676 -, WELLESLEY, Mass., Oct. ...Y ), a biopharmaceutical company,discovering and d...s TLR,Therapeutics(TM), announced today that Pfize...er, has nominated a second TLR9 agonist compound,d...
Other Medicine Technology:Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 2Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 3Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 4Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 5Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development 2Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development 3
BD Visitec Micro Tip Cannulas
BD Visitec Membrane Dissectors
BD Pocket Scleral Blades and Knives
BD Visitec Subretinal Fluid Instruments
Medicine Products: